H19 knockdown suppresses proliferation and induces apoptosis by regulating miR-148b/WNT/β-catenin in ox-LDL -stimulated vascular smooth muscle cells

Lei Zhang, Hailing Cheng, Yuxia Yue, +3

Journal of Biomedical Science

MiR-223/Ect2/p21 signaling regulates osteosarcoma cell cycle progression and proliferation

Jianli Xu, Qi Yao, Yu Hou, +5

Biomedicine & Pharmacotherapy

Tumor BiologyMedicineCancer Cell BiologyTumor SuppressorMicrorna Detection +4

18β‐glycyrrhetinic acid inhibits hepatocellular carcinoma development by reversing hepatic stellate cell‐mediated immunosuppression in mice

Penghao Kuang, Wenxiu Zhao, Wei-xue Su, +6

International Journal of Cancer

GlycobiologyImmunologyPathologyImmune RegulationImmunologic Mechanism +25

miR-301b-3p Regulates Breast Cancer Cell Proliferation, Migration, and Invasion by Targeting NR3C2

Yaohua Fan, Yan Li, Yuzhang Zhu, +5

Journal of Oncology

Xanthatin Induces G2/M Cell Cycle Arrest and Apoptosis in Human Gastric Carcinoma MKN-45 Cells

Lei Zhang, Tao Li, Junshan Ruan, +8

Planta Medica

3‐Dimensional Tissue Is Formed From Cancer Cells In Vitro on Gelfoam^®, But Not on Matrigel^TM

Yasunori Tome, Fuminari Uehara, Sumiyuki Mii, +8

Journal of Cellular Biochemistry

Visfatin promotes osteosarcoma cell migration and invasion via induction of epithelial-mesenchymal transition

Gong Cheng, Changying Liu, Xiujiang Sun, +4

Oncology Reports

The effects of miR-26b-5p on fibroblast-like synovial cells in rheumatoid arthritis (RA-FLS) via targeting EZH2

Pei Hu, Zheng-Sen Dong, Shuang Zheng, +4

Tissue and Cell

InflammationRheumatologyRheumatoid DisorderAnti-inflammatoryAutoimmune Disease +9

MiR-148a suppresses invasion and induces apoptosis of breast cancer cells by regulating USP4 and BIM expression.

Lei Zhang, Meiling Xing, Xingang Wang, +2

PubMed

Tumor BiologyBreast OncologyBreast Cancer CellMedicineBreast Cancer Cells +13

Synergistic effect of nanosecond pulsed electric field combined with low-dose of pingyangmycin on salivary adenoid cystic carcinoma

Wei Qi, Jinsong Guo, Shan Wu, +4

Oncology Reports